Question follow-through · 54543

Life Sciences

To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential impact of NHS England’s criterion for eligibility for indication-specific pricing to demonstrate revenue loss on the UK’s international competitiveness

answeredDepartment of Health and Social Care

About this written question

A written question asks a government minister for information in writing. Parliament publishes the question and any answer.

Answering body
Department of Health and Social Care
Tabled
22 May 2025
Target answer date
2 Jun 2025
Answer
6 Jun 2025 · 15 calendar days after tabling

Elapsed calendar days describe the record timeline, not whether Parliament considers an answer on time.

More questions by this MP on Health and care

Shared topic keywords suggest a connection; they do not establish a follow-up.

Votes on this topic

These Commons divisions share a topic label. The question did not necessarily lead to a vote.

Recorded timeline

  1. 22 May 2025

    Question tabled

    To ask the Secretary of State for Health and Social Care, what assessment he has made of the potential impact of NHS England’s criterion for eligibility for indication-specific pricing to demonstrate revenue loss on the UK’s international competitiveness

  2. 2 Jun 2025

    Target answer date

    Date supplied by the official written-questions record.

  3. 6 Jun 2025

    Answer published

    The Government is taking decisive steps to secure the future of life sciences research in the United Kingdom and to ensure we remain internationally competitive. The upcoming Life Sciences Sector Plan sets out a bold vision to strengthen our world-class r...

Open official record

Official data retrieved 28 Sept 2026.

Later records

Possible follow-up questions

Strong links require the same MP, department and exact heading. Other same-department questions are shown as unreviewed candidates, not as confirmed follow-ups. No debate link is asserted unless a stable source relationship exists.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Health Services

3 Jun 2025 · To ask the Secretary of State for Health and Social Care, pursuant to his Answer of 16 May 2025 to Question 51728, what steps he is taking to ensure that patients (a) improve and (b) protect their own health.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Pharmacy: Fees and Charges

3 Jun 2025 · To ask the Secretary of State for Health and Social Care, whether he plans to prevent spoke pharmacies from charging patients for additional services which are delivered by an outsourced hub partner.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Nurses: Schools

10 Jun 2025 · To ask the Secretary of State for Health and Social Care, how many and what proportion of school nurses have received specialist training in (a) allergy and (b) anaphylaxis management.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Bladder Cancer: Health Services

23 Jun 2025 · To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the adequacy of care for bladder cancer in each region; and if he will hold discussions with NICE guidelines on the time taken to update its guidelines on

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Respiratory Syncytial Virus: Vaccination

24 Jun 2025 · To ask the Secretary of State for Health and Social Care, what estimate his Department has made of the number of (a) hospitalisations and (b) deaths that have been prevented by RSV vaccines administered through the early adopter community pharmacy sites.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Pharmacy: Training

24 Jun 2025 · To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure a sufficient number of Designated Prescribing Practitioners to mentor all new non-medical prescribers.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

NHS: Drugs

18 Jul 2025 · To ask the Secretary of State for Health and Social Care, with reference to Action 28 (i) of the Life Sciences Sector Plan, published on 16 July 2025, what criteria his Department plans to use to identify which medicines have a large number of indications

Unreviewed candidateSame MP and department; topic relationship is unreviewed

NHS: Drugs

18 Jul 2025 · To ask the Secretary of State for Health and Social Care, with reference to Action 28 (i) of the Life Sciences Sector Plan, published on 16 July 2025, what criteria his Department plans to use to identify (a) low affordability risk and (b) strong long-ter

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Cancer: Drugs

18 Jul 2025 · To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 18 June 2025 to Question 54542 on Drug Prices, how many of the commercial arrangements involving indications-specific pricing were for indications for (a) rare and (b) ult

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Contraceptives: Pharmacy

23 Oct 2025 · To ask the Secretary of State for Health and Social Care, how many pharmacies in each Integrated Care Board area in England have registered to provide free Emergency Hormonal Contraception; what proportion of those pharmacies are providing that service; a

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Contraceptives: Pharmacy

23 Oct 2025 · To ask the Secretary of State for Health and Social Care, what plans he has to monitor the provision of emergency hormonal contraception under Patient Group Directive as part of the Pharmacy Contraception and Pharmacy First Services.

Unreviewed candidateSame MP and department; topic relationship is unreviewed

Coronavirus and Influenza: Vaccination

28 Nov 2025 · To ask the Secretary of State for Health and Social Care what estimate he has made of adult COVID-19 and influenza vaccination uptake in 2024–25; and what steps his Department is taking to strengthen communication of vaccine value to the public in respons